Company Filing History:
2 out of 5 
1 out of 10 
1 out of 1 Years Active: 2013-2024
Title: Innovative Contributions of Rudolf Stefan Widmann
Introduction: Rudolf Stefan Widmann, an accomplished inventor based in Purkersdorf, Austria, has made significant strides in the field of pharmaceuticals. With a total of five patents to his name, he has focused on developing solutions for critical medical conditions, particularly in the area of cardiovascular treatments.
Latest Patents: Among his notable inventions is a parenteral esmolol formulation, which provides a ready-to-use intravenous solution for patients suffering from tachycardia. This formulation includes a lyophilized powder of pure esmolol hydrochloride that, when reconstituted, produces a solution at a concentration of 20-100 mg/mL for direct administration. Additionally, he has also patented a pharmaceutical composition for the parenteral administration of ultrashort-effective β-adrenoreceptor antagonists, which boasts high stability without the need for additional adjuvants. This composition combines an ultrashort-effective β-adrenoreceptor antagonist and/or its pharmaceutically acceptable salt with water and a cyclodextrin or its derivative.
Career Highlights: Rudolf has contributed his expertise to several companies, including AOP Orphan Pharmaceuticals AG and AOP Orphan Pharmaceuticals AC, where he engaged in research and development of innovative pharmaceutical therapies. His inventions reflect a deep understanding of the complexities involved in drug formulation and administration.
Collaborations: Throughout his career, Rudolf has had the opportunity to work alongside esteemed colleagues such as Georg Strieder and Ko-Chung Lin. These collaborations have facilitated the exchange of ideas and expertise, further advancing the development of effective medical solutions.
Conclusion: Rudolf Stefan Widmann's innovative spirit and dedication to improving patient care through pharmaceutical advancements underscore his notable contributions to the field. His patents are a testament to his ability to address pressing medical needs with effective and stable formulations. As his work continues to impact the pharmaceutical industry, he remains a key figure to watch in the ongoing advancement of medical technology.